Off Patent
November 2027

Acular LS

ketorolac tromethamine

Abbvie Inc

Solution/drops (ophthalmic) · NDA 021528

Last listed protection ends
November 24, 2027

The FDA lists 1 patent for Acular LS, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Patent 8,008,338
    Claims the drug substance, the drug product and a use (U-1181)
  2. Patent 8,008,338
    Pediatric extension: six more months